If you prefer a practitioner-formulated option, Magnesium Plus is one example of a glycinate-based magnesium approach
The side effect profile of Foundayo observed in clinical trials is consistent with other GLP-1 receptor agonists
But that changed with the approval and launch of the Wegovy pill in December 2025 and then again with the launch of Foundayo in April 2026
This is why GLP-1 medications are typically prescribed as an injection or as an oral pill. Accreditations: MB, ChB, MPH Recent research is looking into how GLP-1 agonists could be delivered by a skin patch in the future, using new methods, because the molecules are too large to pass through the skin
Side effects are similar to those experienced with Semaglutide and Tirzepatide: nausea and gastrointestinal complaints are the most common, but only 7% of patients in a study published in The New England Journal of Medicine1 discontinued the medication due to adverse effects
To ask questions or schedule a consultation with Dr Mary Colman, please use this link: Spotlight: Dr